−0.0095EUR
−362.06 KEUR
43.32 M
About XTACY THERAPEUTICS CORP.
Sector
Industry
CEO
Meris Kott
Website
Headquarters
Vancouver
Founded
1998
FIGI
BBG000G8J520
Xtacy Therapeutics Corp. is an exploration company, which engages in the acquisition and exploration of oil and gas properties. The company was founded on August 31, 1998 and is headquartered in Vancouver, Canada.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange XTACY THERAPEUTICS CORP. stocks are traded under the ticker TT5.
Yes, you can track XTACY THERAPEUTICS CORP. financials in yearly and quarterly reports right on TradingView.
TT5 net income for the last quarter is −181.73 K EUR, while the quarter before that showed 180.57 K EUR of net income which accounts for −200.64% change. Track more XTACY THERAPEUTICS CORP. financial stats to get the full picture.
No, TT5 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, TT5 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade XTACY THERAPEUTICS CORP. stock right from TradingView charts — choose your broker and connect to your account.